Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, An unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysisMOSNIER, Laurent O; BOUMA, Bonno N.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 11, pp 2445-2453, issn 1079-5642, 9 p.Article

Thrombin activatable fibrinolysis inhibitor (TAFI)- : How does thrombin regulate fibrinolysis?BOUMA, Bonno N; MOSNIER, Laurent O.Annals of medicine (Helsinki). 2006, Vol 38, Num 6, pp 378-388, issn 0785-3890, 11 p.Article

Protein C anticoagulant and cytoprotective pathways : PIH: Current understanding of thrombosis and hemostasis-from bench to bedsideGRIFFIN, John H; ZLOKOVIC, Berislav V; MOSNIER, Laurent O et al.International journal of hematology. 2012, Vol 95, Num 4, pp 333-345, issn 0925-5710, 13 p.Conference Paper

Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulinMOSNIER, Laurent O; MEIJERS, Joost C. M; BOUMA, Bonno N et al.Thrombosis and haemostasis. 2001, Vol 85, Num 1, pp 5-11, issn 0340-6245Article

The cytoprotective protein C pathwayMOSNIER, Laurent O; ZLOKOVIC, Berislav V; GRIFFIN, John H et al.Blood. 2007, Vol 109, Num 8, pp 3161-3172, issn 0006-4971, 12 p.Article

The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysisMOSNIER, Laurent O; MEIJERS, Joost C. M; BOUMA, Bonno N et al.Thrombosis and haemostasis. 2001, Vol 86, Num 4, pp 1040-1046, issn 0340-6245Article

Cytoprotective-selective activated protein C therapy for ischaemic stroke : Coagulation proteases and cardiovascular diseaseMOSNIER, Laurent O; ZLOKOVIC, Berislav V; GRIFFIN, John H et al.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 883-892, issn 0340-6245, 10 p.Article

Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46MOSNIER, Laurent O; SINHA, Ranjeet K; BURNIER, Laurent et al.Blood. 2012, Vol 120, Num 26, pp 5237-5246, issn 0006-4971, 10 p.Article

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)BOUMA, Bonno N; MARX, Pauline F; MOSNIER, Laurent O et al.Thrombosis research. 2001, Vol 101, Num 5, pp 329-354, issn 0049-3848Article

Activated protein C variants with normal cytoprotective but reduced anticoagulant activityMOSNIER, Laurent O; GALE, Andrew J; YEGNESWARAN, Subramanian et al.Blood. 2004, Vol 104, Num 6, pp 1740-1744, issn 0006-4971, 5 p.Article

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia ALISMAN, Ton; MOSNIER, Laurent O; LAMBERT, Thierry et al.Blood. 2002, Vol 99, Num 1, pp 175-179, issn 0006-4971Article

Infrared fluorescence for vascular barrier breach in vivo ―A novel method for quantitation of albumin effluxVON DRYGALSKI, Annette; FURLAN-FREGUIA, Christian; MOSNIER, Laurent O et al.Thrombosis and haemostasis. 2012, Vol 108, Num 5, pp 987-997, issn 0340-6245, 11 p.Article

Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutantMOSNIER, Laurent O; ZAMPOLLI, Antonella; GRIFFIN, John H et al.Blood. 2009, Vol 113, Num 23, pp 5970-5978, issn 0006-4971, 9 p.Article

Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysisLISMAN, Ton; LEEBEEK, Frank W. G; MOSNIER, Laurent O et al.Gastroenterology (New York, NY. 1943). 2001, Vol 121, Num 1, pp 131-139, issn 0016-5085Article

Amyloid endostatin Induces endothelial cell detachment by stimulation of the plasminogen activation systemREIJERKERK, Arie; MOSNIER, Laurent O; KRANENBURG, Onno et al.Molecular cancer research. 2003, Vol 1, Num 8, pp 561-568, issn 1541-7786, 8 p.Article

Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice : Kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosityREBEL, Heggert; MOSNIER, Laurent O; BERG, Rob J. W et al.Cancer research (Baltimore). 2001, Vol 61, Num 3, pp 977-983, issn 0008-5472Article

The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentrationMOSNIER, Laurent O; LISMAN, Ton; VAN DEN BERG, H. Marijke et al.Thrombosis and haemostasis. 2001, Vol 86, Num 4, pp 1035-1039, issn 0340-6245Article

Prevalence and Risk Factors for Hypertension in HemophiliaVON DRYGALSKI, Annette; KOLAITIS, Nicholas A; MOSNIER, Laurent O et al.Hypertension (Dallas, Tex. 1979). 2013, Vol 62, Num 1, pp 209-215, issn 0194-911X, 7 p.Article

Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethalityNIESSEN, Frank; FURLAN-FREGUIA, Christian; FERNANDEZ, José A et al.Blood. 2009, Vol 113, Num 12, pp 2859-2866, issn 0006-4971, 8 p.Article

Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human plateletsMOSNIER, Laurent O; BUIJTENHUIJS, Paula; MARX, Pauline F et al.Blood. 2003, Vol 101, Num 12, pp 4844-4846, issn 0006-4971, 3 p.Article

Protein C Inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activationMOSNIER, Laurent O; ELISEN, Marc G. L. M; BOUMA, Bonno N et al.Thrombosis and haemostasis. 2001, Vol 86, Num 4, pp 1057-1064, issn 0340-6245Article